Breast Cancer Staging

Seminars in Roentgenology

Volumn 41, Issue 2, 2006, Pages 91-104

  Whitman, Gary J ^a   Sheppard, Declan G ^b   Phelps, Michael J ^c   Gonzales, Bianca N ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Portiuncula Hospital   (Ireland)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ULTRASONOGRAPHY, MAMMARY; UNITED STATES;

EID: 33646384568     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ro.2006.03.003     Document Type: Article

References (59)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer Statistics, 2004. CA Cancer J Clin 54 1 (2004) 8-29
2. Berg W.A. Imaging the local extent of disease. In: Berg W.A., Feig S.A., Lagios M.D., et al. (Eds). Seminars in Breast Disease, vol. 4. Local Extent of Disease (2001), Saunders, Philadelphia, PA 153-173
3. Mumtaz H., Hall-Craggs M.A., Davidson T., et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169 2 (1997) 417-424
4. Newman L.A., Sahin A.A., Cunningham J.E., et al. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer 91 10 (2001) 1845-1853
5. In: Greene F.L., Page D.L., and Fleming I.D. (Eds). AJCC Cancer Staging Manual. ed 6 (2002), Springer, New York, NY 223-240
6. Kuerer H.M., and Newman L.A. Lymphatic mapping and sentinel lymph node biopsy for breast cancer. developments and resolving controversies. J Clin Oncol 23 8 (2005) 1698-1705
7. Smith R.A., Saslow D., Sawyer K.A., et al. American Cancer Society guidelines for breast cancer screening. update 2003. CA Cancer J Clin 53 3 (2003) 141-169
8. Barth Jr. R.J., Gibson G.R., Carney P.A., et al. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. AJR Am J Roentgenol 184 1 (2005) 324-329
9. Gill P.G., Farshid G., Luke C.G., et al. Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer. Breast 13 1 (2004) 15-22
10. Kauhava L., Immonen-Raiha P., Parvinen I., et al. Lower costs of hospital treatment of breast cancer through a population-based mammography screening programme. Eur J Public Health 14 2 (2004) 128-133
11. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353 17 (2005) 1773-1783
12. American College of Radiology. ACR BI-RADS®-Ultrasound. ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas (2003), American College of Radiology, Reston, VA
13. Soo M.S., Baker J.A., and Rosen E.L. Sonographic detection and sonographically guided biopsy of breast microcalcifications. AJR Am J Roentgenol 180 4 (2003) 941-948
14. Berg W.A., and Gilbreath P.L. Multicentric and multifocal cancer. whole-breast US in preoperative evaluation. Radiology 214 1 (2000) 59-66
15. Moon W.K., Noh D.Y., and Im J.G. Multifocal, multicentric, and contralateral breast cancers. bilateral whole-breast US in the preoperative evaluation of patients. Radiology 224 2 (2002) 569-576
16. Kurtz J.M., Spitalier J.M., Amalric R., et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 18 1 (1990) 87-93
17. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56 5 (1985) 979-990
18. Wanebo H.J., Senofsky G.M., Fechner R.E., et al. Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg 201 6 (1985) 667-677
19. Haagenson C.D. Diseases of the Breast. ed 3 (1986), Saunders, Philadelphia, PA 450
20. Smith B.L., Bertagnolli M., Klein B.B., et al. Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer. Ann Surg 216 1 (1992) 17-21
21. Anastasiadis P.G., Liberis V.A., Koutlaki N.G., et al. Incidence and detection of contralateral breast cancer. Breast J 6 3 (2000) 178-182
22. Khurana K.K., Loosmann A., Numann P.J., et al. Prophylactic mastectomy. pathologic findings in high-risk patients. Arch Pathol Lab Med 124 3 (2000) 378-381
23. Fisher E.R., Fisher B., Sass R., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer. Cancer 54 12 (1984) 3002-3011
24. Khan A., Sabel M.S., Nees A., et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol 12 9 (2005) 697-704
25. Podkrajsek M., Music M.M., Kadivec M., et al. Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 15 5 (2005) 1044-1050
26. Bedrosian I., Bedi D., Kuerer H.M., et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10 9 (2003) 1025-1030
27. Rizzatto G. Towards a more sophisticated use of breast ultrasound. Eur Radiol 11 12 (2001) 2425-2435
28. Altinyollar H., Dingil G., and Berberoglu U. Detection of infraclavicular lymph node metastases using ultrasonography in breast cancer. J Surg Oncol 92 4 (2005) 299-303
29. Yang W.T., Chang J., and Metreweli C. Patients with breast cancer. differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology 215 2 (2000) 568-573
30. de Kanter A.Y., van Eijck C.H., van Geel A.N., et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 86 11 (1999) 1459-1462
31. Parker S.H., Jobe W.E., Dennis M.A., et al. US-guided automated large-core breast biopsy. Radiology 187 2 (1993) 507-511
32. Lindfors K.K., and Rosenquist C.J. Needle core biopsy guided with mammography. a study of cost-effectiveness. Radiology 190 1 (1994) 217-222
33. Parker S.H. Percutaneous large core breast biopsy. Cancer 74 (1994) 256-262 (suppl 1)
34. Liberman L., Feng T.L., Dershaw D.D., et al. US-guided core breast biopsy. use and cost-effectiveness. Radiology 208 3 (1998) 717-723
35. Pisano E.D., Fajardo L.L., Caudry D.J., et al. Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial. results from the Radiologic Diagnostic Oncology Group V. Radiology 219 3 (2001) 785-792
36. Krishnamurthy S., Sneige N., Bedi D.G., et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95 5 (2002) 982-988
37. Kuenen-Boumeester V., Menke-Pluymers M., de Kanter A.Y., et al. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer 39 2 (2003) 170-174
38. Hlawatsch A., Teifke A., Schmidt M., et al. Preoperative assessment of breast cancer. sonography versus MR imaging. AJR Am J Roentgenol 179 6 (2002) 1493-1501
39. Lehman C.D., and Schnall M.D. Imaging in breast cancer. magnetic resonance imaging. Breast Cancer Res 7 5 (2005) 215-219
40. Orel S.G., and Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220 1 (2001) 13-30
41. LaTrenta L.R., Menell J.H., Morris E.A., et al. Breast lesions detected with MR imaging. utility and histopathologic importance of identification with US. Radiology 227 3 (2003) 856-861
42. Liberman L., Morris E.A., Dershaw D.D., et al. Fast MRI-guided vacuum-assisted breast biopsy. initial experience. AJR Am J Roentgenol 181 5 (2003) 1283-1293
43. Orel S.G., Rosen M., Mies C., et al. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy. initial experience. Radiology 238 1 (2006) 54-61
44. Liberman L., Bracero N., Morris E., et al. MRI-guided 9-gauge vacuum-assisted breast biopsy. initial clinical experience. AJR Am J Roentgenol 185 1 (2005) 183-193
45. American College of Radiology. ACR BI-RADS®-Magnetic Resonance Imaging. ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas (2003), American College of Radiology, Reston, VA
46. Liu P.F., Debatin J.F., Caduff R.F., et al. Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis. Br J Radiol 71 845 (1998) 501-509
47. Mussurakis S., Buckley D.L., and Horsman A. Dynamic MR imaging of invasive breast cancer. correlation with tumour grade and other histological factors. Br J Radiol 70 833 (1997) 446-451
48. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233 3 (2004) 830-849
49. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 183 4 (2004) 1149-1157
50. Liberman L., Morris E.A., Dershaw D.D., et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180 4 (2003) 901-910
51. Schnall M.D., Blume J., Bluemke D.A., et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 92 1 (2005) 32-38
52. Bedrosian I., Mick R., Orel S.G., et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98 3 (2003) 468-473
53. Slanetz P.J., Edmister W.B., Yeh E.D., et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 8 3 (2002) 145-148
54. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 2 (2003) 333-341
55. Lehman C.D., Blume J.D., Thickman D., et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer. results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 92 1 (2005) 9-15 discussion 15-16
56. Murray A.D., Staff R.T., Redpath T.W., et al. Dynamic contrast enhanced MRI of the axilla in women with breast cancer. comparison with pathology of excised nodes. Br J Radiol 75 891 (2002) 220-228
57. Stets C., Brandt S., Wallis F., et al. Axillary lymph node metastases. a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging 16 1 (2002) 60-68
58. Esserman L. Integration of imaging in the management of breast cancer. J Clin Oncol 23 8 (2005) 1601-1602
59. Weir L., Worsley D., and Bernstein V. The value of FDG positron emission tomography in the management of patients with breast cancer. Breast J 11 3 (2005) 204-209